沃华医药将变为无实控人状态

Core Viewpoint - The Beijing Third Intermediate People's Court has upheld a second-instance ruling regarding the property dispute between Zhao Bingxian and Lu Juan, resulting in an equal division of their shares in Zhongzheng Wanrong Investment Group, which is the controlling shareholder of WoHua Pharmaceutical [1] Group 1: Legal Proceedings - The court's decision maintains the first-instance ruling from the Tongzhou District People's Court, which mandates that Zhao Bingxian and Lu Juan split their shares in Zhongzheng Wanrong Investment Group equally [1] - The ruling specifically pertains to the shares held by Zhao Bingxian and Lu Juan in Zhongzheng Wanrong Investment Group and does not affect the group's 50.27% stake in WoHua Pharmaceutical [1] Group 2: Impact on Company Control - The outcome of the court ruling results in Zhao Bingxian and Lu Juan each holding 50% of Zhongzheng Wanrong Investment Group, leading to a change in the actual controller of WoHua Pharmaceutical [1] - Following the ruling, the actual controller of WoHua Pharmaceutical transitions from Zhao Bingxian to a state of no actual controller [1]